|10.03.2014 | Friday|
VDI and Rx Vitamins partner on vitamin D test & treat sloution
Simi Valley, CA- Oct 3, 2014-VDI Laboratory and Rx Vitamins for Pets
have entered into a partnership in providing a "test and treat"
solution for the high prevalence of pets with vitamin D insufficiency
There is a growing body of evidence that in dogs and cats, as in
humans, low stores of vitamin D are associated with a wide range of
diseases such as cancer, heart disease, IBD, kidney disease, and...
|08.27.2014 | Wednesday|
New test panels available for companion animals
Simi Valley, CA- August 27, 2014- VDI Laboratory announced today, the
release of two new specialty lab tests for companion animals. The
PTH1-84 Calcemia Panel , available for cats and dogs, is used for the
diagnostic assessment of hypercalcemia and hypocalcemia. The pCNP
Infection Panel, available for dogs, is used in the detection and
therapeutic management of critical infections (sepsis).
"VDI strives to bring...
|06.30.2014 | Monday|
Patterson Vet now offers full line of VDI specialty tests
Simi Valley, CA- June 30, 2014- VDI Laboratory is pleased to announce
the expansion of their specialty lab menu offered through Patterson
Veterinary Supply. A new agreement with Patterson allows the
distributor the ability to carry VDI Laboratory's full, and
expanding, line of specialty lab tests.
"This commitment by Patterson extends the current offering of 3 tests
to 14 total tests," says Steve Gauthier,...
|03.03.2014 | Monday|
Change of Service Names
Simi Valley, CA- Mar 3, 2014- VDI Laboratory has announced that as of
April 1st, a name change will take effect for two of their laboratory
services. Formerly known as VDI-TKcanine+ and VDI-TKfeline+, two of
the lab's specialty cancer blood tests, the new test names will be
TKCANINE CANCER PANEL and TKFELINE CANCER PANEL.
"This change reflects VDI's emphasis on providing specialty
diagnostic tests specifically...
|12.16.2013 | Monday|
Canine & feline vitamin D tests released
Simi Valley, CA- Dec 16, 2013- VDI Laboratory announced the release of
two new tests to their line of specialty diagnostic services.
VitDCANINE and VitDFELINE measure [25(OH)D] levels, an important
precursor to the active hormone 1,25VitD.
"Research continues to show that low stores of vitamin D are
associated with a wide range of benign and malignant disease," says
Steve Gauthier, Director of Clinical Studies...
|06.10.2013 | Monday|
Feline cancer blood test now incorporates a dual-biomarker
Simi Valley, CA- June 10, 2013- VDI Laboratory announced the release
of VDI-TKfeline+, the third dual-biomarker blood panel for the
detection and monitoring of cancer in companion animals. The original
feline test, utilizing a single proliferative biomarker, was released
in April, 2011 and has been widely accepted as an aid for the
differentiation of feline intestinal lymphoma from inflammatory bowel
|04.01.2013 | Monday|
Feline Haptoglobin blood test now available
Simi Valley, CA-April 1, 2013-VDI Laboratory has announced the
availability of VDI-Hpt: the first overnight feline-specific
haptoglobin blood test available in the United States. Haptoglobin
(HPT) is a major acute phase protein in cats, produced mainly in the
liver as a response to inflammation and the release of cytokines.
Serum HPT has been shown to be an effective measure of general
inflammation and the concentration...
|07.25.2012 | Wednesday|
VDI-TKcanine+, a blood test to detect and monitor cancer in dogs, is awarded the Seal of Excellence by the National Canine Cancer Foundation
Phoenix, AZ - (BUSINESS WIRE) - July 25, 2012 - The National
Canine Cancer Foundation (NCCF), a non-profit organization dedicated
to eliminating canine cancer, today announced the awarding of its
‘Seal of Excellence' to VDI-TKcanine+, a blood test to
detect and monitor cancer in dogs, and offered exclusively by
Veterinary Diagnostics Institute (VDI).
Cancer affects one out of every three dogs...
|01.19.2012 | Thursday|
Canine Cancer Screen - VDI launches new blood test
Simi Valley, CA-January 19, 2012-Veterinary Diagnostics Institute,
Inc. (VDI) has released a new test that screens for canine cancer in
the apparently healthy dog. As part of a routine wellness visit,
INCaSe can be used to detect early stages of cancer, or confirm that
the dog is cancer free.
By detecting cancer earlier more effective treatment options are
available, improving prognosis. Using a proprietary...
|09.26.2011 | Monday|
VDI completes study on the prognostic use of TK for canines
Simi Valley, CA-Sept, 2011-Cancer is often unpredictable. Sometimes
it is responsive to therapy, sometimes it is not. The ability to
predict which dogs may have the best chance for survival can help pet
owners make decisions about treatment.
Prognosis is a medical term used to describe the likely outcome of an
illness. Veterinary Diagnostics Institute, INC (VDI) examined how a
biomarker, Thymidine Kinase (TK,)...
|04.25.2011 | Monday|
VDI-TK cancer blood test now available for cats
Simi Valley, CA-April 25, 2011-The innovative biomarker used to
detect cancer, VDI-TK, is now available for use in cats. Veterinary
Diagnostics Institute, Inc. which released VDI-TK for canine use in
2010, is now offering the VDI-TK feline cancer blood test. In
addition to the cancer diagnostic, prognostic and monitoring roles
used in dogs, the feline test brings a new practical use-differential
|03.30.2011 | Wednesday|
VDI launches canine cancer screen study
Simi Valley, CA-March 30, 2011-Veterinary Diagnostics Institute, Inc.
(VDI) is focusing its efforts on screening for canine cancer on
apparently healthy dogs. Certain high cancer risk breeds such as
Golden Retrievers and German Shepherds are currently being enrolled in
a new study being conducted in conjunction with the University of
Missouri. Working with breed clubs across the nation, VDI will
|03.08.2011 | Tuesday|
Biomarker Podcast on Pet Life Radio
Dr. Bernadine Cruz, known as the 'Pet Doctor' with Pet Life
Radio (petliferadio.com) conducts an interview with Randy Ringold,
President and Founder of Veterinary Diagnostics Institute. In the
interview, Mr. Ringold discusses how biomarkers are used to detect and
monitor critical diseases in veterinary medicine. The biomarker
Thymidine Kinase (TK), used for the detection, prognosis and
monitoring of certain...
|11.02.2010 | Tuesday|
Webster the Exclusive Distributor of VDI-TK test for Cancer
Veterinary Diagnostics Institute (VDI) Announces Webster Veterinary
Supply as the Exclusive Distributor of VDI-TK test (Thymidine Kinase)
for the Detection of Cancer
Simi Valley, Calif – (BUSINESS WIRE) – November 2, 2010
– Veterinary Diagnostics Institute, Inc., a specialty
diagnostics services provider for companion animals, today announced
that Webster Veterinary will be VDI’s exclusive...
|10.01.2009 | Thursday|
Veterinary Diagnostics Institute Launches Blood Test for the Detection of Sepsis in Dogs
SIMI VALLEY, Calif.--(BUSINESS WIRE)—Oct 1,
2009—Veterinary Diagnostics Institute, Inc., a Veterinary
Clinical Ventures Company dedicated to the introduction of innovative
biomarkers for companion animals, announces the launch of VDxI pCNP;
the first and only test to detect clinically important infections such
as sepsis in canines. The pCNP test detects N-terminal C-type
natriuretic peptide (NT-proCNP)...
|06.01.2009 | Monday|
Veterinary Diagnostics Institute moves to larger facility
SIMI VALLEY, CA - On June 1, 2009, Veterinary Diagnostics Institute
moved from the Irvine location to it's new larger facility in Simi
Valley, located approximately 40 miles northwest of downtown Los
Angeles, reports the companies founder & president, Randy Ringold.
"Our operation was growing rapidly and our existing space wasn't
accommodating to the business and our future growth plans," Ringold
|02.10.2009 | Tuesday|
Veterinary Diagnostics Institute and the Comparative Internal Medicine Laboratory at the MU College of Veterinary Medicine collaborate in the development of biomarker assay for sepsis
IRVINE, CA - Veterinary Diagnostics Institute(tm) (VDI) announces it
has entered into ongoing clinical studies with Dr. Amy DeClue and the
Comparative Internal Medicine Laboratory at the University of Missouri
College of Veterinary Medicine for the development of a biomarker
assay for detection of canine and feline sepsis. The biomarker assay
will be used to detect concentrations of the peptide NT-proCNP (pCNP)
|12.18.2008 | Thursday|
Exclusive license agreement with Colorado State University Research Foundation (CSURF) and NeoTREX™
IRVINE, CA - Veterinary Diagnostics Institute(tm) (VDI) today entered
into an exclusive license agreement with Colorado State University
Research Foundation (CSURF) and NeoTREX(tm) of Fort Collins, CO for
development of a biomarker assay for detection of canine
The technology, co-invented by faculty at CSU's Animal Cancer
Center (a member of CSU's Cancer Supercluster) and investigators